Login to Your Account

Clinic Roundup

Wednesday, August 3, 2011
Jennerex Inc., of San Francisco, reported positive results from a proof-of-concept trial of JX-594, an oncolytic virus, for metastatic melanoma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription